Amy Dymond1, Stuart Mealing1, Jessica McMaster1, Hayden Holmes1, Lesley Owen2. 1. York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York YO10 5NQ, UK. 2. National Institute for Health and Care Excellence, 10 Spring Gardens, London SW1A 2BU, UK.
Abstract
Background: People with respiratory conditions are susceptible to health problems caused by exposure to indoor air pollutants. An economic framework was developed to inform a guideline developed by National Institute for Health and Care Excellence (NICE) to estimate the required level of efficacy necessary for an intervention to be cost-saving in dwellings across England. Methods: An economic modelling framework was built to estimate the incremental costs pre- and post-implementation of interventions designed to reduce exposure to indoor air pollution within dwellings of varying building-related risk factors and profiles. The intervention cost was varied simultaneously with the relative reduction in symptomatic cases of each health condition to estimate the point at which an intervention may become cost-saving. Four health conditions were considered. Results: People living in dwellings with either an extreme risk profile or usable floor area <90m2 have the greatest capacity to benefit and save National Health Service (NHS) costs from interventions at any given level of effectiveness and upfront cost. Conclusions: At any effectiveness level, the threshold for the upfront intervention cost to remain cost-saving is equivalent across the different home characteristics. The flexible model can be used to guide decision-making under a range of scenarios.
Background: People with respiratory conditions are susceptible to health problems caused by exposure to indoor air pollutants. An economic framework was developed to inform a guideline developed by National Institute for Health and Care Excellence (NICE) to estimate the required level of efficacy necessary for an intervention to be cost-saving in dwellings across England. Methods: An economic modelling framework was built to estimate the incremental costs pre- and post-implementation of interventions designed to reduce exposure to indoor air pollution within dwellings of varying building-related risk factors and profiles. The intervention cost was varied simultaneously with the relative reduction in symptomatic cases of each health condition to estimate the point at which an intervention may become cost-saving. Four health conditions were considered. Results:People living in dwellings with either an extreme risk profile or usable floor area <90m2 have the greatest capacity to benefit and save National Health Service (NHS) costs from interventions at any given level of effectiveness and upfront cost. Conclusions: At any effectiveness level, the threshold for the upfront intervention cost to remain cost-saving is equivalent across the different home characteristics. The flexible model can be used to guide decision-making under a range of scenarios.
Entities:
Keywords:
cost-effectiveness analysis; economic model; indoor air pollution; public health guidance
Authors: David C Shelledy; Shawn R McCormick; Terry S LeGrand; Jaime Cardenas; Jay I Peters Journal: Heart Lung Date: 2005 Nov-Dec Impact factor: 2.210
Authors: Maritta S Jaakkola; Reginald Quansah; Timo T Hugg; Sirpa A M Heikkinen; Jouni J K Jaakkola Journal: J Allergy Clin Immunol Date: 2013-09-10 Impact factor: 10.793
Authors: Rhiannon T Edwards; Richard D Neal; Pat Linck; Nigel Bruce; Linda Mullock; Nick Nelhans; Diana Pasterfield; Daphne Russell; Ian Russell; Louise Woodfine Journal: Br J Gen Pract Date: 2011-11 Impact factor: 5.386
Authors: Tursynbek A Nurmagambetov; Sarah Beth L Barnett; Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Deidre D Crocker; Gema G Dumitru; Stella Kinyota Journal: Am J Prev Med Date: 2011-08 Impact factor: 5.043
Authors: Sotiris Vardoulakis; Evanthia Giagloglou; Susanne Steinle; Alice Davis; Anne Sleeuwenhoek; Karen S Galea; Ken Dixon; Joanne O Crawford Journal: Int J Environ Res Public Health Date: 2020-12-02 Impact factor: 3.390
Authors: Kuan Ken Lee; Rong Bing; Joanne Kiang; Sophia Bashir; Nicholas Spath; Dominik Stelzle; Kevin Mortimer; Anda Bularga; Dimitrios Doudesis; Shruti S Joshi; Fiona Strachan; Sophie Gumy; Heather Adair-Rohani; Engi F Attia; Michael H Chung; Mark R Miller; David E Newby; Nicholas L Mills; David A McAllister; Anoop S V Shah Journal: Lancet Glob Health Date: 2020-11 Impact factor: 26.763